WebDoctor Encyclopedia

Central nervous system Childhood

Pineoblastoma

Pineoblastoma is a rare, fast-growing grade 4 brain tumour of the pineal gland that mainly affects young children. It often causes hydrocephalus and eye movement problems and is treated with surgery, chemotherapy and radiotherapy.

Medically reviewed Last reviewed October 17, 2026

What is pineoblastoma?

Pineoblastoma is a rare, fast-growing brain tumour that starts in the pineal gland. This small gland, deep in the centre of the brain, makes the hormone melatonin, which helps to control the sleep-wake cycle.

Pineoblastoma is an embryonal tumour, meaning it is made of immature cells that look like the cells of a developing embryo. The World Health Organization classifies it as grade 4, the most aggressive grade (Louis et al., 2021).

It mainly affects children, especially under the age of 10, but it can also occur in teenagers and adults. Because the pineal gland sits next to the channels that drain spinal fluid, pineoblastoma often causes hydrocephalus, a build-up of fluid and pressure in the brain.

Pineoblastoma can spread through the cerebrospinal fluid (CSF) to other parts of the brain and spine. Treatment usually combines surgery, chemotherapy and radiotherapy. The outlook is much better for older children than for very young ones (Mynarek et al., 2017).

1. Key facts at a glance

Feature Details
Type of tumour Embryonal tumour of the pineal gland, WHO grade 4
How common Very rare; under 1% of childhood brain tumours
Typical age Mostly children, median about 5-8; also infants and adults
Main site Pineal region, at the back of the third ventricle
Key symptoms Headache, vomiting, problems looking upwards, double vision
Genetic links DICER1 syndrome; RB1 (trilateral retinoblastoma)
Main treatment Surgery, chemotherapy and radiotherapy to the brain and spine
Outlook About 60-80% long-term survival in older children; poorer in infants

2. Types and molecular groups

The pineal gland can give rise to several tumours. Pineoblastoma is the most aggressive of the pineal parenchymal tumours:

Tumour WHO grade Behaviour
Pineocytoma 1 Slow-growing; usually adults; often cured by surgery
Pineal parenchymal tumour of intermediate differentiation 2 or 3 In between
Papillary tumour of the pineal region 2 or 3 Usually adults
Pineoblastoma 4 Fast-growing; usually children

Research has shown that pineoblastoma itself includes four main molecular groups, which differ in age and outlook (Li et al., 2020; Liu et al., 2020):

Molecular group Typical age Main gene changes Outlook
PB-miRNA1 Children DICER1, DROSHA or DGCR8 changes Intermediate
PB-miRNA2 Older children DICER1, DROSHA or DGCR8 changes Better
PB-MYC/FOXR2 Infants MYC gain, FOXR2 activation Poor
PB-RB1 Infants RB1 loss Poor

3. Causes and risk factors

Most pineoblastomas occur without a known cause. Some are linked with inherited conditions:

Condition Notes
DICER1 syndrome An inherited change in DICER1; also linked with pleuropulmonary blastoma and other tumours (de Kock et al., 2014)
Hereditary retinoblastoma (RB1) Children with inherited retinoblastoma can develop a pineoblastoma, known as trilateral retinoblastoma (de Jong et al., 2015)
Other rare gene changes Being studied

Children with pineoblastoma are therefore often offered genetic testing. Children with hereditary retinoblastoma have brain MRI checks in early childhood in some centres.

Pineoblastoma is not infectious, and it is not caused by anything parents did or did not do. No lifestyle, dietary or environmental cause has been found.

4. How does it look

On scans

MRI with contrast is the main test. It usually shows:

Feature Description
Location A mass in the pineal region, behind the third ventricle
Size Often larger than 3 cm at diagnosis
Appearance Lobulated, partly solid, enhancing with contrast; may contain cysts or calcium
Hydrocephalus Enlarged fluid spaces caused by blockage of the aqueduct
Spread Coating of the brain or spinal cord surface, or nodules in the spine

MRI of the whole spine is done to look for spread through the CSF, which is present in about a quarter to a third of patients at diagnosis.

Under the microscope

Pineoblastoma consists of densely packed small, round, blue cells with little cytoplasm and many dividing cells. Cells may form rosettes, small ring-shaped groups.

Staining for synaptophysin and other neuronal markers is usually positive. Doctors also check tumour markers to rule out germ cell tumours, which are another common cause of a pineal mass. A specialist neuropathologist usually reviews the sample, and DNA methylation testing is increasingly used to confirm the diagnosis.

Visible signs

The tumour itself is not visible, but pressure on nearby brain areas can cause signs that others notice:

Sign What it looks like
Parinaud syndrome The eyes cannot look upwards; pupils react poorly to light
“Sunsetting” eyes Eyes turned downwards, especially in babies
Enlarging head In babies, from hydrocephalus
Unsteady walking Clumsiness or poor balance
Drowsiness From raised pressure in the head

5. Symptoms

Raised pressure in the head

Most symptoms come from hydrocephalus:

  • Headaches, often worse in the morning
  • Nausea and vomiting, especially in the morning
  • Tiredness and sleepiness
  • Irritability and changes in behaviour
  • Blurred vision from swelling at the back of the eyes (papilloedema)

Eye and movement symptoms

  • Difficulty looking up (part of Parinaud syndrome)
  • Double vision
  • Jerky eye movements when trying to look up
  • Unsteadiness and clumsiness

Babies and young children

  • Rapidly growing head and bulging soft spot
  • Vomiting and poor feeding
  • Loss of developmental skills

Spread to the spine

  • Back pain
  • Weakness or numbness in the legs
  • Bladder or bowel problems

When to seek medical advice

Seek urgent help for severe headache with vomiting, drowsiness, confusion or a seizure.

See a doctor promptly if a child has headaches that wake them up, repeated morning vomiting, double vision or difficulty looking upwards.

6. Diagnosis

Test Purpose
MRI of the brain and spine Shows the tumour, hydrocephalus and any spread
Blood and CSF tumour markers (AFP, beta-hCG) Help exclude germ cell tumours
CSF cytology Looks for tumour cells in the spinal fluid
Surgery or biopsy Confirms the diagnosis
DNA methylation profiling Identifies the molecular group
Genetic testing For DICER1, RB1 and other inherited changes
Eye examination Checks for retinoblastoma and raised pressure

Other tumours of the pineal region

Several different tumours can grow in the pineal region, and they are treated very differently. Getting the exact diagnosis is therefore essential:

Tumour Typical age Key clue
Germinoma Teenagers and young adults, mostly boys Raised beta-hCG in some; very sensitive to radiotherapy
Non-germinomatous germ cell tumour Children and teenagers Raised AFP or beta-hCG in blood or CSF
Pineocytoma Adults Slow-growing; well-defined on MRI
Pineal cyst Any age Common, fluid-filled and harmless
Pineoblastoma Mostly young children Large, lobulated mass; normal tumour markers

If tumour markers are clearly raised, a germ cell tumour can sometimes be diagnosed without surgery. When markers are normal, a biopsy is needed.

Risk groups

Doctors divide patients into risk groups to guide treatment (Liu et al., 2020):

Risk group Features
Standard risk Age over 3, no spread, little tumour left after surgery
High risk Spread through the CSF or significant tumour remaining
Young children Under 3; treatment avoids or delays radiotherapy

7. Treatment

Pineoblastoma is treated at a specialist paediatric neuro-oncology centre.

Treating hydrocephalus

The first step is often to relieve pressure in the head. This may be done with an endoscopic third ventriculostomy (ETV), a small opening that lets CSF bypass the blockage, or with a shunt. A biopsy and CSF sample can often be taken during the same procedure.

Surgery

Surgeons try to remove as much tumour as safely possible. The pineal region lies deep among important veins and brain structures, so complete removal is not always possible. Surgery may cause temporary eye movement problems, which often improve.

Recovery after surgery

Most children spend a short time in intensive care after the operation, then several days on the ward. Some have temporary problems with eye movements, balance, speech or alertness, which often improve over weeks.

Physiotherapists, occupational therapists and speech therapists help with recovery. Radiotherapy and chemotherapy usually begin within a few weeks of surgery.

Radiotherapy

Age group Radiotherapy
Older children and adults Craniospinal radiotherapy to the whole brain and spine, with a higher dose to the tumour area
Children under about 3 Usually avoided or delayed because of its effects on the developing brain

Chemotherapy

Situation Chemotherapy
With and after radiotherapy Combinations such as cisplatin, cyclophosphamide and vincristine, similar to medulloblastoma treatment
Young children Intensive chemotherapy, sometimes high-dose chemotherapy with stem cell rescue, to delay or avoid radiotherapy
Relapse Further chemotherapy, radiotherapy or clinical trials

Side effects

Side effect Notes
Low blood counts and infections During chemotherapy
Hearing loss From cisplatin
Tiredness During and after radiotherapy
Hair loss Usually temporary
Sickness Controlled with anti-sickness medicines

8. Outlook (prognosis)

The outlook depends strongly on age, spread and molecular group (Tate et al., 2012; Mynarek et al., 2017; Liu et al., 2020):

Group Approximate long-term survival
Older children, no spread About 70-80% or more
Older children with spread About 40-60%
Children under 3 Much lower, often under 30-40%
PB-miRNA2 group Best outcomes
PB-MYC/FOXR2 and PB-RB1 groups Poorest outcomes

Why molecular testing matters

Two children with pineoblastomas that look the same under the microscope can have very different outlooks. Molecular testing helps doctors to identify children who may do well with standard treatment and those who might benefit from more intensive treatment or a clinical trial.

In the future, molecular groups are expected to guide treatment more directly, as they already do for medulloblastoma.

9. Long-term effects and follow-up

Children are followed up with regular MRI scans of the brain and spine for many years. Survivors may need support for late effects:

Late effect Support
Learning and memory School support and neuropsychology assessment
Growth and puberty Hormone tests and treatment by an endocrinologist
Hearing Hearing aids if needed
Thyroid function Regular blood tests after spinal radiotherapy
Eye movement and vision Eye clinic follow-up
Second tumours Particularly in DICER1 or RB1 carriers

10. Living with pineoblastoma

  • Ask for a named key worker to coordinate care
  • Work with the school on learning support and time off
  • Seek emotional support for the whole family, including brothers and sisters
  • Ask about genetic counselling for the family
  • Keep a record of treatment details for future follow-up
  • Ask about melatonin or sleep support if sleep patterns change after treatment
  • Plan breaks and rest, as tiredness can last for months after radiotherapy

11. Frequently asked questions

Question Answer
Is pineoblastoma the same as a pineal cyst? No. Pineal cysts are common and harmless; pineoblastoma is a malignant tumour
Will my child need radiotherapy? Older children usually do; very young children may have chemotherapy instead
Is it inherited? Usually not, but some cases are linked with DICER1 or RB1 changes
Will the eye problems get better? Often they improve after pressure is relieved and treatment begins
Can adults get pineoblastoma? Yes, but rarely
What is proton beam therapy? A type of radiotherapy that can reduce the dose to healthy brain tissue; it is often used for children
Can the tumour come back? Yes, most relapses happen in the first few years, which is why regular scans are needed

12. Questions to ask your care team

  • What molecular group is the tumour?
  • Has the tumour spread to the spine?
  • How much of the tumour was removed?
  • What treatment plan do you recommend for my child’s age?
  • Should we have genetic testing?
  • What late effects should we look out for?
  • Is proton beam therapy an option?
  • Are there clinical trials suitable for my child?
  • Who should we call if symptoms such as headache or vomiting return?

Resources

  1. Louis, D.N. et al. (2021) ‘The 2021 WHO Classification of Tumors of the Central Nervous System: a summary’, Neuro-Oncology, 23(8), pp. 1231-1251.
  2. Li, B.K. et al. (2020) ‘Pineoblastoma segregates into molecular sub-groups with distinct clinico-pathologic features: a Rare Brain Tumor Consortium registry study’, Acta Neuropathologica, 139(2), pp. 223-241.
  3. Liu, A.P.Y. et al. (2020) ‘Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trials’, Acta Neuropathologica, 139(2), pp. 259-271.
  4. Mynarek, M. et al. (2017) ‘Evaluation of age-dependent treatment strategies for children and young adults with pineoblastoma: analysis of pooled European Society for Paediatric Oncology (SIOP-E) and US Head Start data’, Neuro-Oncology, 19(4), pp. 576-585.
  5. Tate, M. et al. (2012) ‘The long-term postsurgical prognosis of patients with pineoblastoma’, Cancer, 118(1), pp. 173-179.
  6. de Kock, L. et al. (2014) ‘Germ-line and somatic DICER1 mutations in pineoblastoma’, Acta Neuropathologica, 128(4), pp. 583-595.
  7. de Jong, M.C. et al. (2015) ‘The incidence of trilateral retinoblastoma: a systematic review and meta-analysis’, American Journal of Ophthalmology, 160(6), pp. 1116-1126.
  8. Snuderl, M. et al. (2018) ‘Recurrent homozygous deletion of DROSHA and microduplication of PDE4DIP in pineoblastoma’, Nature Communications, 9(1), p. 2868.
  9. National Cancer Institute (2026) Childhood Central Nervous System Embryonal Tumors Treatment (PDQ) – Health Professional Version. Available at: https://www.cancer.gov/types/brain/hp/child-cns-embryonal-treatment-pdq (Accessed: October 2026).

Prepared by the editorial team, October 2026.